← back to search

Harold E. Paulus

University of California, Los Angeles · US
Area of research
Rheumatology · Pathology and Forensic Medicine
Research interest
Research interests include Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments, Systemic Lupus Erythematosus Research, and Systemic Sclerosis and Related Diseases.
h-index
58
citations
18,509
works
237
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Improvement of High‐Density Lipoprotein Function in Patients With Early Rheumatoid Arthritis Treated With Methotrexate Monotherapy or Combination Therapies in a Randomized Controlled Trial
Arthritis & Rheumatology 2016cited by 64position: middledoi
Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two‐Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial
Arthritis & Rheumatology 2015cited by 50position: middledoi
Comprehensive Appraisal of Magnetic Resonance Imaging Findings in Sustained Rheumatoid Arthritis Remission: A Substudy
Arthritis Care & Research 2015cited by 33position: lastdoi
Changes in Lipoproteins Associated With Methotrexate Therapy or Combination Therapy in Early Rheumatoid Arthritis: Results From the Treatment of Early Rheumatoid Arthritis Trial
Arthritis & Rheumatism 2013cited by 138position: middledoi
Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis
Lara D. Veeken 2013cited by 121position: lastdoi
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
Arthritis Care & Research 2012cited by 1,797position: middledoi
A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial
Arthritis & Rheumatism 2012cited by 388position: middledoi
Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis
Annals of the Rheumatic Diseases 2012cited by 224position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jeffrey R. Curtis · University of Alabama at Birmingham5 papers (2012–2016)Stacey S. Cofield · University of Alabama at Birmingham5 papers (2012–2016)Joan M. Bathon · New York University5 papers (2012–2016)Larry W. Moreland · Queen Mary University of London5 papers (2012–2016)James R. O’Dell · VA Nebraska Western Iowa Health Care System5 papers (2012–2016)Christina Charles‐Schoeman · University of California, Los Angeles4 papers (2012–2016)S. Louis Bridges · Hospital for Special Surgery4 papers (2012–2015)Iris Navarro‐Millán · Hospital for Special Surgery3 papers (2013–2016)Yuen Yin Lee · University of California, Los Angeles3 papers (2012–2016)David Elashoff · Core Laboratories (United States)3 papers (2013–2016)Veena K. Ranganath · University of California, Los Angeles3 papers (2012–2015)Lang Chen · Zhongda Hospital Southeast University3 papers (2013–2016)— · 2 papers (2012–2015)E. William St. Clair · Duke University2 papers (2012–2015)Ani Shahbazian · University of California, Los Angeles2 papers (2015–2016)Srinivasa T. Reddy · University of California, Los Angeles2 papers (2012–2016)Paul Maranian · Arizona State University2 papers (2013–2015)Shuo Yang · University of Alabama at Birmingham2 papers (2013–2015)Theodore J. Hahn · University of California, Los Angeles1 papers (2013–2013)Víctor Grijalva · University of Wisconsin–Madison1 papers (2012–2012)